Clear Street’s LumiraDx Limited Warrant LMDXW Stock Holding History

Clear Street’s Portfolio LMDXW Stock Details LMDXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$3	–	1364
2023 Q2	$3	Buy	+100	New	+$6	﹤0.01%	1309

Other funds holding LMDXW

CVS Health Woonsocket, Rhode Island $212M AUM 19.39% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Covalent Partners Concord, Massachusetts $17.6M AUM 2.91% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street's LMDXW Position: Q3 2023 in Review

Clear Street sold out of LumiraDx Limited Warrant (LMDXW) in Q3 2023, closing a stake of 100 shares — an estimated $3 sold.

Clear Street first reported a position in LMDXW in Q2 2023 and held it in 1 quarter. The position peaked at $3 in Q2 2023. 15 funds tracked by Wall St. Rank hold LMDXW as of Q3 2023.

Clear Street reported no remaining LumiraDx Limited Warrant position as of Q3 2023 after selling out during the quarter.
Clear Street sold 100 LumiraDx Limited Warrant shares in Q3 2023, an estimated $3.
Clear Street first reported a position in LumiraDx Limited Warrant in Q2 2023 and held it in 1 quarter.
Clear Street's LumiraDx Limited Warrant position peaked at $3 in Q2 2023.
15 funds tracked by Wall St. Rank held LumiraDx Limited Warrant as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.